XORTX Therapeutics (XRTX) - 2024 Q1 - Quarterly Report

Exhibit 99.1 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS As at and for the three months ended March 31, 2024 and 2023 (Unaudited - expressed in U.S. Dollars) XORTX THERAPEUTICS INC. Condensed Interim Consolidated Statements of Financial Position (Unaudited - expressed in U.S. Dollars) | | | March 31, | December 31, | | --- | --- | --- | --- | | | Note | 2024 | 2023 | | | | $ | $ | | Assets | | | | | Current | | | | | Cash | 5 | 3,835,440 | 3,447,665 | | Accounts receivable | | 30,883 | 60,711 | | Pr ...